Readmission was more common among publically insured, black patients presenting with comorbidities including hypertension and diabetes.
Baseline renal function tests may predict the risk of preeclampsia and preterm birth for pregnant women with hypertension.
Even those who are in overall poor health and medically frail could benefit from hypertension interventions.
Addressing factors that lead to lack of adherence to antihypertensive therapy in elderly patients is crucial to improving outcomes.
Women who had gestational diabetes may be able to reduce their risk of developing hypertension by eating a healthy diet.
Results from a study presented at ACC in Chicago suggest that statins can be more widely used in patients considered to be intermediate risk for cardiovascular disease.
Renin angiotensin system blockers have similar risks and outcomes compared with other antihypertensive agents for patients with diabetes.
Investigators found an increased risk of ischemic stroke among all patients within 21 days following initiation of alpha-blocker therapy.
Premature birth has been associated with a number of adverse health conditions.
Treating hypertension can reduce the risk of major cardiovascular disease events regardless of blood pressure at the start of treatment.
The FDA has approved Uptravi (selexipag) for the treatment of pulmonary arterial hypertension in adult patients.
New guidelines released by the American Heart Association and the American Thoracic Society are the first for the diagnosis and treatment of pediatric pulmonary hypertension.
Reducing blood pressure to a lower level than recommended in hypertension guidelines may further decrease the risk of heart attack and stroke.
The USPSTF recommends regular screenings for high blood pressure in adults. These results should be confirmed by home monitoring.
Doctors must assess for the presence of pulmonary hypertension in patients with lung disease, COPD, or emphysema, among other conditions.
Hypertensive disorders are the most common medical complications of pregnancy, affecting 5-8% of all pregnancies in the U.S.
Reaching a systolic pressure of 120 mm HG reduces the risk of heart attack, heart failure, and stroke by a third.
A number of evidence-based, nonpharmacologic approaches are available for patients with hypertension.
Chinese adults with hypertension who added folic acid to enalapril saw a small but significant stroke risk decrease.
Clinicians should help patients with CAD lower their blood pressure to reduce the risk of heart attack and stroke.
A spike in hypertension-related death was seen in both genders and was most marked among those aged 45 to 64 years and those aged over 85 years.
The new recommended levels could have a particularly negative effect on Hispanics and non-Hispanic blacks.
Systolic reading of 150 should prompt immediate action to prevent poor outcomes.
In overweight adults, a low-glycemic diet did not improve insulin sensitivity, lipid levels, or blood pressure.
Full implementation of the new hypertension guidelines would reduce deaths and treatment costs for patients aged 45 to 74 years with cardiovascular disease.
Nitric oxide levels were greater in the blueberry powder group compared with baseline levels, while no changes were observed in the control group.
Patients with chronic insomnia who took longer than 14 minutes to fall asleep had a 300% higher risk of hypertension.
Perindopril arginine and amlodipine besylate may be used as initial therapy if a patient is likely to need multiple drugs to achieve their blood pressure goals.
Women who had an early or late age of menstruation onset have an increased risk for coronary heart disease, stroke and hypertension.
Improvements in hypertension, cholesterol control, and smoking cessation rates among participants enrolled in a cardiovascular disease prevention program were seen.